Jul 28, 2023

Featuring perspectives from Ms Kristen B Battiato and Dr Jennifer Woyach, including the following topics:

• Introduction (0:00)
• Case: A woman in her early 70s responding to ibrutinib for 4 years (27:07)
• Case: A woman in her early 80s with TP53-mutant, del(17p) disease responding to acalabrutinib (38:02)
• Case: A man in his mid 50s with chronic lymphocytic leukemia/small lymphocytic leukemia treated for a year with obinutuzumab followed by venetoclax; no evidence of disease for 3 years (43:29)
• Case: A Cuban woman in her mid 60s with multiregimen-recurrent disease, now receiving venetoclax (53:17)

NCPD information and select publications